Basal cell carcinoma of skin of breast
ICD-10 C44.511 is a billable code used to indicate a diagnosis of basal cell carcinoma of skin of breast.
Basal cell carcinoma (BCC) is the most common form of skin cancer, arising from the basal cells in the epidermis. When it occurs on the breast, it is often due to prolonged sun exposure, although it can also develop in areas not typically exposed to sunlight. BCC is characterized by slow growth and a low likelihood of metastasis, making it less aggressive than other skin cancers. Clinically, it may present as a pearly or waxy bump, a flat scar-like lesion, or a sore that does not heal. Surgical excision is the primary treatment, with the goal of achieving clear surgical margins to minimize recurrence. Reconstruction may be necessary depending on the size and location of the excised lesion. Proper coding for BCC of the breast requires careful documentation of the lesion's characteristics, treatment performed, and any reconstructive procedures undertaken. Understanding the nuances of skin cancer coding, particularly in relation to surgical margins and the implications of sun exposure, is crucial for accurate billing and compliance.
Detailed descriptions of the lesion, treatment plans, and follow-up care.
Diagnosis and treatment of skin lesions, including BCC, and management of post-surgical care.
Ensure clear documentation of margins and any reconstructive procedures performed.
Comprehensive treatment plans, including chemotherapy or radiation if applicable.
Management of advanced skin cancers and coordination of care with dermatology.
Document any systemic treatments and their indications.
Used when excising a BCC from the breast.
Document size, location, and margins of the excised lesion.
Dermatologists should ensure detailed operative notes.
The primary treatment for basal cell carcinoma is surgical excision, which aims to remove the cancerous tissue while ensuring clear margins to prevent recurrence.
